FORT COLLINS, Colo., Sept. 24 /PRNewswire/ -- InVitria (http://www.InVitria.com) addressed attendees at Cambridge Healthtech Institute's 4th Annual "Optimizing Cell Culture Development" Conference on September 15-16 in Boston, Massachusetts and announced its most recent results optimizing cell culture media using its product line of animal free cell culture ingredients. (http://www.healthtech.com/ocb/overview.aspx?c=562)
In a presentation of scientific studies with InVitria's Cellastim and Lacromin, Steve Pettit, Director of InVitria's Cell Culture Group, noted, "The growth and productivity results in CHO cell lines are quite impressive and not achievable with other sources of albumin or transferrin supplements. Cellastim has shown growth and productivity up to 50% better than the next best alternative. Similar impressive results with the use of Lacromin have previously been published by our team(1)," said Pettit.
"We continue to show powerful results of Cellastim and Lacromin in cell culture media for a variety of cell lines including CHO, Hybridoma, Vero and NS0 cells. Since these are well defined supplements, they help our customers achieve both their regulatory and manufacturing goals. These are the only supplements available that not only improve cell culture performance, but do this while maintaining a defined and animal free media," said Scott Deeter, InVitria's President.
About InVitria (http://www.InVitria.com)
InVitria has developed animal free cell culture ingredients that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry. InVitria's animal free product line includes:
-- Cellastim - Cellastim is a recombinant albumin that is used as a
Copyright©2008 PR Newswire.
All rights reserved